Yehya Alaa, Numan Mohammad, Matalqah Laila
Yarmouk University (YU), Irbid, Jordan.
Jordan University of Science and Technology (JUST), Irbid, Jordan.
Glob Pediatr Health. 2021 Feb 22;8:2333794X21992170. doi: 10.1177/2333794X21992170. eCollection 2021.
. To provide a qualitative and a quantitative analysis of H1-antihistamines pharmacological uses pattern among children (<6 years old) and to evaluate the parental-related awareness. . A cross-sectional study was carried out at 5 retail pharmacies in Jordan over 5 months (October/2019-February/2020). Parents who requested any of H1-antihistmine agent for a child (<6 years) were invited to participate. . A total of 516 children, most of them were toddlers (1-3) years, received at least 1 H1-antihistamine. More than half of the cases received H1-antihistamine as self-medication (56.3%). Sedating antihistamine agents were the most frequently used among children (<6 years old) (77.9%) among which Chlorpheniramine maleate was the most commonly used agent (62.9%). About half of the children (47.0%) received H1-antihistamine to induce sleep. Whereas, 21.7% and 12.9% received them to manage flu, and allergic rhinitis (AR), respectively. Around 66.6% of the cases were classified as off-label use. Most of the parents (80.5%) were aware of the sedative adverse effects of H1-antihistamines, whereas a fewer number (31.9%) were aware of their cognitive effects. Finally, more than two thirds of parents (79.7%) were unfamiliar with off-label drug use in children. . Despite the availability of less-sedating H1-antihistamines with a wide safety and efficacy record, the use of sedating H1-antihistamines remains popular in children.
对6岁以下儿童使用H1抗组胺药的药理用途模式进行定性和定量分析,并评估与父母相关的认知情况。在约旦的5家零售药店进行了为期5个月(2019年10月至2020年2月)的横断面研究。邀请为6岁以下儿童购买任何H1抗组胺药的父母参与。共有516名儿童至少接受过1种H1抗组胺药治疗,其中大多数是1至3岁的幼儿。超过一半的病例(56.3%)将H1抗组胺药作为自我用药。镇静性抗组胺药是6岁以下儿童中最常用的(77.9%),其中马来酸氯苯那敏是最常用的药物(62.9%)。约一半的儿童(47.0%)使用H1抗组胺药来诱导睡眠。而分别有21.7%和12.9%的儿童使用它们来治疗流感和过敏性鼻炎(AR)。约66.6%的病例被归类为超说明书用药。大多数父母(80.5%)知道H1抗组胺药的镇静副作用,而只有少数(31.9%)知道其认知方面的影响。最后,超过三分之二的父母(79.7%)不了解儿童超说明书用药情况。尽管有安全性和有效性记录良好的非镇静性H1抗组胺药,但镇静性H1抗组胺药在儿童中的使用仍然很普遍。